satavaptan has been researched along with ouabain in 1 studies
Studies (satavaptan) | Trials (satavaptan) | Recent Studies (post-2010) (satavaptan) | Studies (ouabain) | Trials (ouabain) | Recent Studies (post-2010) (ouabain) |
---|---|---|---|---|---|
95 | 11 | 30 | 16,357 | 72 | 747 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abassi, Z; Azzam, ZS; Berger, G; Bishara, B; Guetta, J; Ismael-Badarneh, R; Klorin, G; Sabo, E; Tal, R | 1 |
1 other study(ies) available for satavaptan and ouabain
Article | Year |
---|---|
Vasopressin-2 receptor antagonist attenuates the ability of the lungs to clear edema in an experimental model.
Topics: Alveolar Epithelial Cells; Amiloride; Animals; Antidiuretic Hormone Receptor Antagonists; Cells, Cultured; Colchicine; In Vitro Techniques; Indoles; Male; Morpholines; Ouabain; Permeability; Pulmonary Alveoli; Pulmonary Edema; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Sodium-Potassium-Exchanging ATPase; Spiro Compounds; Vasopressins | 2012 |